The company says it has consolidated its position as the global pharmaceutical industry's largest and most experienced clinical technology organisation
Clinical technology organisation ClinPhone has announced financial results for the year ending February 2004.
Turnover to February 2004 was $37.25 million.
This compares with $30 million for the 2002-2003 financial year and a represents an increase in sales of almost 25%.
Significant long-term contracts have also been secured, guaranteeing 60% of the 2004-2005 financial target and long-term projects stretching through until 2009.
ClinPhone reports its total order book value to be in excess of $57million. The company says it has consolidated its position as the global pharmaceutical industry's largest and most experienced clinical technology organisation, having supported well over 1000 clinical trials (of which more than 300 are currently live) in over 80 countries and 70 languages.
During the last financial year ClinPhone also purchased US operation TrialTrac and its TrialWorks system, a clinical and regulatory data tracking system.
This clinical trial management software is a brand new addition to the ClinPhone portfolio, and provides clients with a pragmatic software product that enables them to manage multiple numbers of studies from their own desktop.
A major new partnership agreement was also secured with Healthcare Technology Systems (HTS) - the world authority in research, development, and validation of computer-administered clinical rating instruments. This guarantees ClinPhone a unique and exclusive worldwide perpetual license for the use of HTS's assessments on any device or medium used in Phase I - IV clinical trials funded by pharmaceutical, biotechnology or medical device companies.
Staff levels have also continued to increase during the last financial year.
The company has over 400 staff with over 100 employees out of US offices in Princeton, Chicago, Boston, and Saratoga. European facilities are located in Brussels, Belgium and Heidelberg, Germany with corporate headquarters in Nottingham, United Kingdom.
Recruitment has been across the board, with significant increase in the size of the company's business development team and corresponding growth in its operational and customer support teams.
"We are delighted that we have been able to broaden both the customer base and the service portfolio at the same time as returning our best sales figures ever," commented group financial director Steven Kent.
"What is particularly satisfying is the quality of the long-term order book which is a direct result of our ongoing investment in the development of new and innovative services which give our customers strategic advantage.
